Physician profile
Brian E Johnson
NPI 1033302526
$879.51
in general payments reported to CMS, 2019-2025
11 companies · $143 in 2025
The $143 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $227 · 2022: $90.50 · 2023: $187 · 2024: $232 · 2025: $143.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $562.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $562.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $220.63 | 2021-2024 | Durolane, Durolane |
| Smith+Nephew, INC. | $144.10 | 2024 | Pico |
| Heron Therapeutics, INC. | $130.32 | 2021-2022 | |
| Vertex Pharmaceuticals Incorporated | $91.17 | 2025 | |
| Merck Sharp & Dohme LLC | $76.92 | 2021-2024 | Bridion |
| Depuy Synthes Sales INC. | $59.55 | 2021-2025 | Monovisc, Orthovisc |
| Fidia Pharma USA INC. | $52.84 | 2021 | |
| Zimmer Biomet Holdings, INC. | $38.22 | 2025 | Gel-One Cross-Linked Hyaluronate |
| Convatec INC. | $25.59 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $23.77 | 2023 | Exparel, Iovera, Zilretta |
| Heraeus Medical, LLC. | $16.40 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.